Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1141 to 1155 of 1300 results for heart OR cardi* OR arrythmia

  1. What is the optimal timing of administration of carbohydrate drinks as part of a preoperative fasting strategy?

    for intraoperative fluid maintenance. Cardiac output monitoring Older evidence suggested that cardiac output monitoring...

    Research recommendation
    Published
    26 October 2020

  2. Transjugular intrahepatic portosystemic shunt:- What is the quality of life in people who have had a transjugular intrahepatic portosystemic shunt (TIPS)?

    TIPS (for example, hepatic encephalopathy, shunt blockages, infection and cardiac problems) have on each person. It is therefore...

    Research recommendation
    Published
    11 January 2024

  3. Treatment of convulsive status epilepticus (that is, not just refractory): What is the most effective and safest AED to treat: established (usually lasting longer than 30 minutes) convulsive status epilepticus refractory convulsive status epilepticus?

    used with care and close monitoring because of the risk of hypotension and cardiac arrhythmia. Sodium valproate and levetiracetam are...

    Research recommendation
    Published
    13 August 2021

  4. What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can be obtained when using a complete individual patient-based outcomes meta-analysis data set compared with using published outcomes data?

    summary data. Source guidance details Comes from guidance Cardiovascular disease: risk assessment and reduction, including lipid...

    Research recommendation
    Published
    9 June 2015

  5. What is the effectiveness of age alone and other routinely available risk factors compared with the formal structured multifactorial risk assessment to identify people at high risk of developing CVD?

    high risk. Source guidance details Comes from guidance Cardiovascular disease: risk assessment and reduction, including lipid...

    Research recommendation
    Published
    9 June 2015

  6. What is the effectiveness of statins and/or other LDL-cholesterol-lowering treatment in people with type 1 diabetes?

    diabetes. Source guidance details Comes from guidance Cardiovascular disease: risk assessment and reduction, including lipid modification

    Research recommendation
    Published
    9 June 2015

  7. What is the effectiveness of statin therapy in older people?

    and atherosclerosis is an age-associated process. Few trials assessing cardiovascular outcomes have recruited many people older than 80...

    Research recommendation
    Published
    9 June 2015

  8. What is the efficacy and safety of COVID-specific antiviral drugs in combination with other COVID-specific antiviral drugs or COVID-specific neutralising monoclonal antibodies in people who do not need supplemental oxygen and are within 7 days of symptom onset?

    over• immunosuppression• obesity• hypertension• chronic lung disease• cardiovascular disease• cerebrovascular disease• active cancer•...

    Research recommendation
    Published
    9 March 2022

  9. What is the efficacy and safety of remdesivir for people who have been vaccinated against COVID-19?

    over• immunosuppression• obesity• hypertension• chronic lung disease• cardiovascular disease• cerebrovascular disease• active cancer•...

    Research recommendation
    Published
    9 March 2022

  10. How safe are drugs used to treat bipolar disorder in pregnancy and the postnatal period?

    preterm delivery) congenital malformations (for example, spinal cord and cardiac malformation) baby outcomes (for example, mortality,...

    Research recommendation
    Published
    13 July 2017

  11. What are the appropriate indications, effectiveness and safety of LDL apheresis in people with heterozygous FH?

    heterozygous FH. In addition, there is limited published evidence on the cardiovascular outcome of such patients treated with LDL...

    Research recommendation
    Published
    15 November 2019

  12. What is the clinical effectiveness and rate of adverse events of statin therapy using atorvastatin 20 mg per day compared with atorvastatin 40 mg per day and atorvastatin 80 mg per day in people without established CVD?

    prevention of CVD and should be recommended for those at 10% risk of cardiovascular events as assessed using the QRISK2 calculator....

    Research recommendation
    Published
    9 June 2015

  13. Use of hearing aids and incidence of dementia:- In adults with hearing loss, does the use of hearing aids reduce the incidence of dementia?

    susceptibility, environmental factors or age-related factors such as cardiovascular disease. Hearing loss may cause dementia either...

    Research recommendation
    Published
    10 December 2018

  14. The effects of stopping and/or switching drug treatments to control blood glucose levels: In adults with type 2 diabetes, what are the effects of stopping and/or switching drug treatments to control blood glucose levels, and what criteria should inform the decision?

    diabetes control (HbA1c levels), hypoglycaemic risk, weight gain, and cardiovascular morbidity and mortality. In addition, there is...

    Research recommendation
    Published
    16 December 2021

  15. Long-term outcomes associated with blood glucose lowering agents: In adults with type 2 diabetes, what are the long‑term effects of blood glucose lowering therapies such as dipeptidyl peptidase‑4 (DPP‑4) inhibitors, sodium–glucose cotransporter‑2 (SGLT2) inhibitors and meglitinides?

    particularly newer agents in terms of efficacy and adverse events (for example, cardiovascular outcomes). Randomised controlled trials...

    Research recommendation
    Published
    16 December 2021